BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 18988121)

  • 1. Electrical faults and the hydrogen hypercycle.
    Williams A
    Clin Med (Lond); 2007 Apr; 7(2):102. PubMed ID: 17491490
    [No Abstract]   [Full Text] [Related]  

  • 2. The preclinical discovery and development of ezogabine for the treatment of epilepsy.
    Jankovic S; Ilickovic I
    Expert Opin Drug Discov; 2013 Nov; 8(11):1429-37. PubMed ID: 24053653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sixth annual Ion Channel Retreat Vancouver, Canada, June 23-25, 2008.
    Choy N; Davis A; Brugger S; Liang S
    Assay Drug Dev Technol; 2008 Dec; 6(6):759-64. PubMed ID: 19231940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion channel targets - select biosciences' fourth annual conference.
    Holmqvist M; Maduke M
    IDrugs; 2008 Nov; 11(11):795-8. PubMed ID: 18988121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for potassium channel openers in neuronal ion channel disorders?
    Lawson K
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2269-80. PubMed ID: 11060806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.
    Gunthorpe MJ; Large CH; Sankar R
    Epilepsia; 2012 Mar; 53(3):412-24. PubMed ID: 22220513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACS chemical neuroscience molecule spotlight on Potiga (Ezogabine).
    Hopkins CR
    ACS Chem Neurosci; 2012 Aug; 3(8):632. PubMed ID: 22896808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The h-channel: a potential channelopathy in epilepsy?
    Poolos NP
    Epilepsy Behav; 2005 Aug; 7(1):51-6. PubMed ID: 15961349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.
    Splinter MY
    Clin Ther; 2012 Sep; 34(9):1845-56.e1. PubMed ID: 22917854
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.